Diagnos (TSE:ADK) has released an update.
Diagnos Inc. has announced its annual general and special meeting for shareholders on September 25, 2024, to discuss key corporate matters, including financial statements, director elections, and an amendment to the stock option plan. The AI-driven health detection company encourages shareholders to vote by proxy and offers videoconferencing for non-voting participants.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
